{"filing":{"accession_number":"0000009326-26-000032","cik":"0000009326","ticker":"BCPC","company_name":"BALCHEM CORP","form":"8-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"bcpc-20261023.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/9326/000000932626000032/bcpc-20261023.htm"},"events":[{"id":37425,"run_id":34497,"accession_number":"0000009326-26-000032","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Balchem Corporation disclosed quarterly financial results for Q3 2026 (ended September 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $290.7 million (up 8.6% YoY), net earnings of $46.7 million (up 16.0% YoY), adjusted EBITDA of $80.3 million (up 12.4% YoY), and diluted EPS of $1.46 (up from $1.24). This is a standard quarterly earnings release filed under Item 2.02, with comprehensive financial tables and segment performance details.","company_name":"BALCHEM CORP","ticker":"BCPC","filing_date":"2026-10-23","form":"8-K","submitted_at":null,"items":[{"id":42132,"accession_number":"0000009326-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Balchem Corporation disclosed quarterly financial results for Q3 2026 (ended September 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $290.7 million (up 8.6% YoY), net earnings of $46.7 million (up 16.0% YoY), adjusted EBITDA of $80.3 million (up 12.4% YoY), and diluted EPS of $1.46 (up from $1.24). This is a standard quarterly earnings release filed under Item 2.02, with comprehensive financial tables and segment performance details.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T11:21:38.141453+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42132,"accession_number":"0000009326-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Balchem Corporation disclosed quarterly financial results for Q3 2026 (ended September 30, 2026) via press release attached as Exhibit 99.1. The disclosure reports net sales of $290.7 million (up 8.6% YoY), net earnings of $46.7 million (up 16.0% YoY), adjusted EBITDA of $80.3 million (up 12.4% YoY), and diluted EPS of $1.46 (up from $1.24). This is a standard quarterly earnings release filed under Item 2.02, with comprehensive financial tables and segment performance details.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T11:21:38.141453+00:00","company_name":"BALCHEM CORP","ticker":"BCPC","filing_date":"2026-10-23"}]}